McKesson (MCK) reported fiscal Q4 adjusted earnings late Thursday of $10.12 per diluted share, up from $6.18 a year earlier.
Analysts polled by FactSet expected $9.83.
Revenue for the quarter ended March 31 rose to $90.82 billion from $76.36 billion a year earlier.
Analysts expected $94.30 billion.
For its fiscal 2026, the company is projecting adjusted EPS of $36.75 to $37.55. Analysts are looking for $36.81.
McKesson on Thursday also disclosed plans to spin off its Medical-Surgical Solutions unit into a stand-alone company, stating it will provide further details on the timing and structure of the separation as the process advances.
The company's shares were up over 2% in recent after-hours activity.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。